Financials CUC Inc.

Equities

9158

JP3347080008

Healthcare Facilities & Services

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-14 am EDT			5-day change	1st Jan Change
1,635 ^JPY	+7.99%		+5.28%	-26.78%

Apr. 25	Japanese Shares Lead Asia Sell-Off as Tech Stocks Weigh; CUC Sumps 19% Despite Upbeat Earnings	MT
Apr. 25	CUC's Attributable Net Income Jumps 7% in Fiscal Year Ended March; Stock Slumps 14%	MT

Valuation

Fiscal Period: March	2024	2025	2026
Capitalization ¹	47,931	-	-
Enterprise Value (EV) ¹	89,417	62,441	71,412
P/E ratio	28.8 x	20.3 x	14.3 x
Yield	-	-	-
Capitalization / Revenue	2.4 x	1.11 x	0.96 x
EV / Revenue	2.71 x	1.45 x	1.43 x
EV / EBITDA	16.2 x	9.43 x	8.46 x
EV / FCF	-8.44 x	-60.9 x	-50 x
FCF Yield	-11.8%	-1.64%	-2%
Price to Book	2.9 x	1.58 x	1.45 x
Nbr of stocks (in thousands)	29,315	-	-
Reference price ²	1,635	1,635	1,635
Announcement Date	4/24/24	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March	2023	2024	2025	2026
Net sales ¹	35,210	33,025	43,133	49,979
EBITDA ¹	-	5,524	6,622	8,444
EBIT ¹	3,683	3,737	4,138	5,565
Operating Margin	10.46%	11.32%	9.59%	11.13%
Earnings before Tax (EBT) ¹	3,634	4,138	4,025	4,975
Net income ¹	2,423	2,595	2,362	3,343
Net margin	6.88%	7.86%	5.48%	6.69%
EPS ²	113.9	93.99	80.61	114.0
Free Cash Flow ¹	-	-10,590	-1,026	-1,429
FCF margin	-	-32.07%	-2.38%	-2.86%
FCF Conversion (EBITDA)	-	-	-	-
FCF Conversion (Net income)	-	-	-	-
Dividend per Share ²	-	-	-	-
Announcement Date	5/18/23	4/24/24	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 S1	2025 Q3	2025 Q4
Net sales ¹	7,663	7,683	15,346	8,021	9,657	10,190	10,405	20,800	10,825	11,782
EBITDA ¹	-	1,358	-	1,243	1,690	1,550	1,620	3,170	1,710	1,720
EBIT ¹	834	945	1,778	842	1,117	975	990	1,970	1,065	1,108
Operating Margin	10.88%	12.3%	11.59%	10.5%	11.57%	9.57%	9.51%	9.47%	9.84%	9.4%
Earnings before Tax (EBT) ¹	793	887	1,680	751	1,707	850	920	1,770	1,010	920
Net income ¹	482	557	1,039	461	1,095	527	570	1,097	626	576
Net margin	6.29%	7.25%	6.77%	5.75%	11.34%	5.17%	5.48%	5.27%	5.78%	4.89%
EPS ²	21.25	19.13	40.09	15.73	38.17	16.76	21.79	-	19.44	24.73
Dividend per Share	-	-	-	-	-	-	-	-	-	-
Announcement Date	7/26/23	10/25/23	10/25/23	1/29/24	4/24/24	-	-	-	-	-

¹JPY in Million²JPY

Estimates

Balance Sheet Analysis

Fiscal Period: March	2023	2024	2025	2026
Net Debt ¹	17,332	10,178	14,511	23,482
Net Cash position ¹	-	-	-	-
Leverage (Debt/EBITDA)	-	1.843 x	2.191 x	2.781 x
Free Cash Flow ¹	-	-10,590	-1,026	-1,429
ROE (net income / shareholders' equity)	22.9%	13.3%	8.1%	10.7%
ROA (Net income/ Total Assets)	-	8.07%	5.5%	7.65%
Assets ¹	-	32,167	42,955	43,699
Book Value Per Share ²	533.0	932.0	1,034	1,126
Cash Flow per Share	171.0	159.0	-	-
Capex ¹	5,583	4,859	7,500	8,133
Capex / Sales	15.86%	14.71%	17.39%	16.27%
Announcement Date	5/18/23	4/24/24	-	-

¹JPY in Million²JPY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for CUC Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,635 JPY

Average target price

2,700 JPY

Spread / Average Target

+65.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CUC INC.	-26.78%	284M
HCA HEALTHCARE, INC.	+18.41%	83.07B
CVS HEALTH CORPORATION	-29.08%	70.89B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.59%	28.32B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.08%	17.73B
FRESENIUS SE & CO. KGAA	+2.07%	17.43B
QUEST DIAGNOSTICS INCORPORATED	+0.93%	15.64B
REDE D'OR SÃO LUIZ S.A.	+6.78%	13.46B
FRESENIUS MEDICAL CARE AG	+8.40%	12.82B
NATERA, INC.	+68.45%	12.69B

Other Healthcare Facilities & Services